Activiomics, Kyowa Hakko Kirin deal

Activiomics will use its Targeted In-depth Quantification of Cell Signaling (TIQUAS) mass spectrometry technology to identify signaling mechanisms of lead compounds from Kyowa. The deal is part of a J...